Although much of this review has been concerned with atherosclerosis, it is notable that at least the apoA-I mimetics have been shown to be useful as potential therapies for other inflammatory disorders, such as respiratory inflammations, intestinal inflammation, chronic arthritis, and even some cancer models (Van Lenten et al., 2008a; Cedo et al., 2016). Here, APOA1 is linked to gastroenteritis.